Isthmus Partners’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
SP
PAM
CIM
AAMU
JIC
WG
Isthmus Partners's CL Position: Q2 2026 in Review
Isthmus Partners increased its Colgate-Palmolive (CL) stake by 1.8% in Q2 2026, buying an estimated $229K and bringing the position to 148,235 shares worth $13.6M. The position accounts for 1.31% of the portfolio, ranked #27.
Isthmus Partners first reported a position in CL in Q1 2017 and has held it in 30 quarters since. The position peaked at $14M in Q3 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Isthmus Partners held 148,235 shares of Colgate-Palmolive worth $13.6M as of Q2 2026.
- Isthmus Partners bought 2,615 Colgate-Palmolive shares in Q2 2026, an estimated $229K.
- Colgate-Palmolive made up 1.31% of Isthmus Partners's portfolio in Q2 2026, its #27 holding.
- Isthmus Partners first reported a position in Colgate-Palmolive in Q1 2017 and has held it in 30 quarters since.
- Isthmus Partners's Colgate-Palmolive position peaked at $14M in Q3 2024.
- 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.